Technology | Artificial Intelligence | March 19, 2018

Philips Launches HealthSuite Insights AI Platform for Healthcare

Online marketplace offers curated, readily available AI assets for license

Philips Launches HealthSuite Insights AI Platform for Healthcare

March 19, 2018 — Philips recently announced the launch of HealthSuite Insights, including the Insights Marketplace, to support the advancing adoption of analytics and artificial intelligence (AI) in key healthcare domains. Making their debut at the 2018 Healthcare Information and Management Systems Society Conference and Exhibition (HIMSS18), March 5-9 in Las Vegas, HealthSuite Insights gives data scientists, software developers, clinicians and healthcare providers access to advanced analytic capabilities to curate and analyze healthcare data and offers them tools and technologies to build, maintain, deploy and scale AI-based solutions. Insights Marketplace will provide the healthcare industry's first ecosystem where curated AI assets from Philips and others are readily available for license.

AI-based solutions have great potential to improve patient outcomes and care efficiency, according to Philips. However, developing and deploying AI solutions for healthcare use cases can be time consuming, resource intensive and expensive. HealthSuite Insights eases the logistical challenges of deploying AI solutions in research and clinical environments. It accelerates the development of analytics solutions, and reduces development and total cost of AI solutions.

"The quality of your AI is only as good as the quality of the data you feed into it," said Jeroen Tas, Chief Innovation & Strategy Officer Philips. "We have designed HealthSuite Insights to be used by the people who work with patient data on a daily basis and have the contextual understanding; including doctors, clinicians and hospital managers.” He added that the platform gives users the ability to bring all the relevant patient information together, curate the data and use the power of AI to support precision diagnosis, personalized therapy, early intervention and greater hospital efficiency.

The tools and technologies available through HealthSuite Insights already enable the machine learning and deep learning applications in Philips' diagnostic imaging solutions, patient monitoring solutions, and oncology and genomics offerings. Enabled by the platform, Philips leverages AI across these offerings, by combining it with other technologies and a deep understanding of the clinical, operational and personal context to augment care professionals and patients/consumers.

Philips' Insights Marketplace initially offers assets supplied by Philips – including assets developed by scientists at Philips Research. Medically validated Philips assets will be added later this year. In late 2018, the Insights Marketplace will be further expanded to include assets submitted by third parties.

AI assets built using the Insights Platform are designed to be secure regardless of the execution environment, with sophisticated identity and access management, integrated blockchain services, and data collection and management services built in. The Insights platform can be deployed on a healthcare cloud infrastructure such as the Philips HealthSuite Digital Platform, or on premise at a provider site.

For more information: www.usa.philips.com/healthcare

 

Related Content

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Sponsored Content | Case Study | Artificial Intelligence | April 09, 2020
As the largest independent imaging group in Michigan with 10 locations across the state,...
The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief.

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief. Find more images from the COVID-19 pandemic.

 

Feature | Coronavirus (COVID-19) | April 08, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
News | Artificial Intelligence | April 02, 2020
April 2, 2020 — In the face of the COVID-19 pand